MediciNova (MNOV)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	40.36 mm	40.36 mm	40.36 mm	40.36 mm	40.36 mm	40.36 mm
Cash burn (monthly)	640.29 k	886.64 k	1.06 mm	1.06 mm	643.91 k	886.91 k
Cash used (since last report)	1.52 mm	2.11 mm	2.52 mm	2.51 mm	1.53 mm	2.11 mm
Cash remaining	38.84 mm	38.25 mm	37.84 mm	37.85 mm	38.83 mm	38.25 mm
Runway (months of cash)	60.7	43.1	35.7	35.8	60.3	43.1

Beta Read what these cash burn values mean

Financial data from MediciNova earnings reports.

Institutional ownership, Q3 2024

MNOV institutional ownership history Ownership history

21.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	31	34	-8.8%
Opened positions	4	5	-20.0%
Closed positions	7	7	–
Increased positions	5	2	+150.0%
Reduced positions	11	15	-26.7%

13F shares	Current	Prev Q	Change
Total value	10.15 bn	6.91 bn	+46.9%
Total shares	10.43 mm	10.29 mm	+1.4%
Total puts	6.00 k	3.80 k	+57.9%
Total calls	9.40 k	7.20 k	+30.6%
Total put/call ratio	0.6	0.5	+20.9%

Largest owners	Shares	Value	Change
3D Investment Partners Pte.	5.50 mm	$14.25 mm	0.0%
Essex Woodlands Management	1.11 mm	$2.32 bn	0.0%
BlackRock	700.58 k	$1.47 bn	NEW
Vanguard	623.33 k	$1.31 bn	0.0%
Geode Capital Management	505.97 k	$1.06 bn	+10.3%
C Citigroup	447.96 k	$940.71 mm	0.0%
UBS UBS	305.49 k	$641.53 mm	+204926.2%
Renaissance Technologies	186.60 k	$391.86 mm	-11.1%
STT State Street	157.20 k	$330.12 mm	0.0%
Bridgeway Capital Management	145.15 k	$304.81 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
BlackRock	700.58 k	+700.58 k	NEW
BLK BlackRock	0.00	-694.94 k	EXIT
UBS UBS	305.49 k	+305.34 k	+204926.2%
BMO Bank of Montreal	0.00	-132.23 k	EXIT
Charles Schwab Investment Management	71.51 k	-63.29 k	-47.0%
Geode Capital Management	505.97 k	+47.20 k	+10.3%
Susquehanna International	57.00 k	+45.80 k	+409.0%
BAC Bank of America	76.35 k	-42.31 k	-35.7%
Renaissance Technologies	186.60 k	-23.40 k	-11.1%
Citadel Advisors	1.43 k	-16.80 k	-92.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MNOV insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
12 Feb 25	Beaver Carolyn	Stock Option Common Stock	Grant	Acquire A	No	No	1.84	24,500	45.08 k	24,500
12 Feb 25	Matsuda Kazuko	Employee Stock Option Common Stock	Grant	Acquire A	No	No	1.84	100,000	184.00 k	100,000
12 Feb 25	Nicole Lemerond	Stock Option Common Stock	Grant	Acquire A	No	No	1.84	24,500	45.08 k	24,500
12 Feb 25	Nagao Hideki	Stock Option Common Stock	Grant	Acquire A	No	No	1.84	24,500	45.08 k	24,500
12 Feb 25	Iwaki Yuichi	Employee Stock Option Common Stock	Grant	Acquire A	No	No	1.84	100,000	184.00 k	100,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

21 Feb 25

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.